OXFORD, England & TORONTO--(BUSINESS WIRE)--Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it ...
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...
A new study published in JCO Clinical Cancer Informatics demonstrates that machine learning models incorporating patient-reported outcomes and wearable sensor data can predict which patients with ...
We combined natural language processing and large language models with state-of-the-art machine learning techniques and approaches to treat unbalanced data sets and determine the best solution to ...
Talk about a breath of fresh air. Researchers have developed a groundbreaking device that may one day make detecting lung cancer as easy as exhaling. “We built a screening tool that could allow ...
Please provide your email address to receive an email when new articles are posted on . Machine learning models can predict which patients receiving lung cancer therapy may need urgent care visits.
Please provide your email address to receive an email when new articles are posted on . The FDA recently cleared Qure.ai’s qCT LN Quant AI solution for lung nodule management. Early detection, precise ...
BEIJING, 4 February (BelTA - China Daily) - A Chinese research team has developed the world's first blood-based diagnostic kit that can tell whether lung nodules are benign or cancerous, including ...
The cancer diagnostics industry is evolving rapidly as advances in biotechnology, data analytics and precision medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results